Oluseyi A Adejumo1, Enajite I Okaka2, Chimezie G Okwuonu3, Ikponmwosa O Iyawe2, Oluwole O Odujoko3. 1. Department of Internal Medicine, Kidney Care Centre, Ondo, Ondo State, Nigeria. 2. Department of Internal Medicine, University of Benin Teaching Hospital, Benin, Benin City, Edo State, Nigeria. 3. Department of Internal Medicine, Federal Medical Centre, Umuahia, Abia State, Nigeria.
Abstract
BACKGROUND: Cardiovascular disease is the major cause of hospitalization and mortality in chronic kidney disease (CKD). C-reactive protein (CRP) is a marker of cardiovascular disease and predictor of mortality in CKD patients. CKD patients with elevated CRP should be identified early with institution of measures to treat cardiovascular risk factors in order to reduce attendant mortality. AIMS: Determination of serum CRP levels in CKD patients and associated factors. METHODS: This was a case-control study involving 80 consecutive CKD patients and 40 control subjects without CKD. Data obtained from participants included demographics, body mass index (BMI), and aetiology of CKD. Serum CRP levels, albumin, creatinine and lipid profile were determined. Cases and controls were compared. P values <0.05 were taken as significant. RESULTS: The mean age of the CKD subjects was 49.09±16.85 years. The median CRP value was significantly higher in the CKD group compared to controls (p=<0.001). Low, average and high cardiovascular event risk according to CRP values were present in 51(63.8%), 13(16.2%) and 16(20%) of the CKD patients respectively. Cardiovascular event risk was significantly higher in CKD subjects (p=<0.001). Serum creatinine, BMI, triglyceride and atherogenic index of plasma correlated positively with CRP. Estimated glomerular filtration rate (eGFR), high density lipoprotein-cholesterol and albumin correlated negatively with CRP. Elevated serum CRP was significantly predicted by low eGFR and high BMI on multivariate analysis. CONCLUSION: Chronic kidney disease patients have increased cardiovascular event risk. Interventions aimed at reducing weight and treating dyslipidaemia should be instituted early in order to reduce this risk.
BACKGROUND:Cardiovascular disease is the major cause of hospitalization and mortality in chronic kidney disease (CKD). C-reactive protein (CRP) is a marker of cardiovascular disease and predictor of mortality in CKDpatients. CKDpatients with elevated CRP should be identified early with institution of measures to treat cardiovascular risk factors in order to reduce attendant mortality. AIMS: Determination of serum CRP levels in CKDpatients and associated factors. METHODS: This was a case-control study involving 80 consecutive CKDpatients and 40 control subjects without CKD. Data obtained from participants included demographics, body mass index (BMI), and aetiology of CKD. Serum CRP levels, albumin, creatinine and lipid profile were determined. Cases and controls were compared. P values <0.05 were taken as significant. RESULTS: The mean age of the CKD subjects was 49.09±16.85 years. The median CRP value was significantly higher in the CKD group compared to controls (p=<0.001). Low, average and high cardiovascular event risk according to CRP values were present in 51(63.8%), 13(16.2%) and 16(20%) of the CKDpatients respectively. Cardiovascular event risk was significantly higher in CKD subjects (p=<0.001). Serum creatinine, BMI, triglyceride and atherogenic index of plasma correlated positively with CRP. Estimated glomerular filtration rate (eGFR), high density lipoprotein-cholesterol and albumin correlated negatively with CRP. Elevated serum CRP was significantly predicted by low eGFR and high BMI on multivariate analysis. CONCLUSION:Chronic kidney diseasepatients have increased cardiovascular event risk. Interventions aimed at reducing weight and treating dyslipidaemia should be instituted early in order to reduce this risk.
Authors: Ana I González; Fernando Brites; Alicia Elbert; Leonardo Gómez-Rosso; Gabriela Berg; Regina Wikinski; Laura Schreier Journal: Medicina (B Aires) Date: 2010 Impact factor: 0.653
Authors: Margus Annuk; Inga Soveri; Mihkel Zilmer; Lars Lind; Johannes Hulthe; Bengt Fellström Journal: J Nephrol Date: 2005 Nov-Dec Impact factor: 3.902
Authors: Vandana Menon; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Santica M Marcovina; Andrew S Levey; Mark J Sarnak Journal: Am J Kidney Dis Date: 2003-07 Impact factor: 8.860
Authors: Erik Hansson; Jason Glaser; Ilana Weiss; Ulf Ekström; Jenny Apelqvist; Christer Hogstedt; Sandra Peraza; Rebekah Lucas; Kristina Jakobsson; Catharina Wesseling; David H Wegman Journal: Occup Environ Med Date: 2019-11 Impact factor: 4.402
Authors: Hai-Hua Chuang; Rong-Ho Lin; Wen-Cheng Li; Wei-Chung Yeh; Yen-An Lin; Jau-Yuan Chen Journal: Int J Environ Res Public Health Date: 2020-08-13 Impact factor: 4.614